1138

Factor VIII Inhibitor - Hepzyme Treated

Order Code: 1138 Get Requisition Form
Test Information Icon
Test Information
The chromogenic factor VIII inhibitor assay uses bovine reagents, is insensitive to emicizumab and lupus anticoagulant, and is adversely affected by the presence of direct factor X inhibitors or very high concentrations of heparin (greater than 2 U/mL). The addition of hepzyme in this assay will neutralize the influence of heparin.
Also Known As Icon
Also Known As
  • AHF
  • Anti-Hemophilic Factor
  • Emicizumab
  • F8
  • Factor 8
  • Factor VIII
  • FVIII
Disease State Icon
Disease State
Hemophilia
Test Type Icon
Test Type
Functional/Serologic Test
Sample Notes Icon
Sample Notes
Citrated Plasma (light blue top)
Requested Volume Icon
Requested Volume
2 mL
Minimum / Pediatric Volume Icon
Minimum / Pediatric Volume
1.5 mL
Shipping Information Icon
Shipping Information
Frozen
CPT Codes Icon
CPT Codes
  • 85335
  • 85525
Method Icon
Method
Chromogenic Bethesda Titer
Turnaround Time Icon
Turnaround Time
7 days
New York State Approval Icon
New York State Approval
Approved
DEX Z-Code™ Icon
DEX Z-Code™
No
 
Our Experts
Research investigators, postdoctoral fellows and laboratory staff at Versiti Blood Research Institute and Diagnostic Laboratories.
 
Hematology Testing
Versiti provides von Willebrand factor tests, aHUS diagnosis, hemophilia lab tests and other laboratory diagnosis of bleeding and clotting disorders.
 
Requisitions
Access requisitions for Versiti Diagnostic Laboratories.